Addressing Alzheimer’s Disease Diagnostics and Barriers to Care Roundtable: A Policy Approach
- This event has passed.
December 9, 2024 @ 9:30 am - 3:30 pm EST
The Society for Women’s Health Research convened an interdisciplinary Alzheimer’s disease diagnostics roundtable of public health researchers and professionals, policymakers, and health care providers for a closed, roundtable meeting. The roundtable discussed advancements and breakthroughs in diagnosis and staging; federal policy; caregiving; and improving access to more timely and earlier diagnosis, among other topic areas.
This is an SWHR Event.
Roundtable Participants
Maheen Adamson, PhD, Clinical Professor, Neurology, Stanford University
Sheena Aurora, MD, Vice President of Neurology, C2N Diagnostics
Joel Braunstein, MD, MBA, Co-Founder and CEO of C2N Diagnostics
Melanie Chadwick, CRNP, Gerontological Research Nurse Practitioner (GNP), Georgetown University
Wen Dombrowski, MD, MBA, Adjunct Professor, CATALAIZE
Rebecca Edelmayer, PhD, Vice President of Scientific Engagement, Alzheimer’s Association
Hampus Hillerstrom, MS Economics, MS Health Science & Technology, MBA, President and CEO, LuMind IDSC
Ian Kremer, JD, Executive Director, LEAD Coalition
Lisa McGuire, PhD, FGSA, Vice President of Strategic Alliances and Practice Innovation, Gerontological Society of America
Jennifer Pollack, JD, Director of Access Policy, Alzheimer’s Association
Jennifer Snow, MPH, Founder of Apteka
Deanna R. Willis, MD, Professor of Family Medicine and Vice Chair of Research, Indiana University School of Medicine
Sponsor
Support for this program has been provided by Eli Lilly & Co and Roche. SWHR maintains independence and editorial control over program development, content, and work products.
